3-42263527-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_000729.6(CCK):c.104G>A(p.Arg35Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,613,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000729.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCK | NM_000729.6 | c.104G>A | p.Arg35Gln | missense_variant | 4/5 | ENST00000396169.7 | |
CCK | NM_001174138.3 | c.104G>A | p.Arg35Gln | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCK | ENST00000396169.7 | c.104G>A | p.Arg35Gln | missense_variant | 4/5 | 1 | NM_000729.6 | P1 | |
CCK | ENST00000334681.9 | c.104G>A | p.Arg35Gln | missense_variant | 2/3 | 1 | P1 | ||
CCK | ENST00000434608.1 | c.104G>A | p.Arg35Gln | missense_variant | 2/3 | 1 | P1 | ||
CCK | ENST00000484359.1 | n.175G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000611 AC: 15AN: 245534Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133840
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1460988Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 726778
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74384
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at